ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

10.03

-0.12 (-1.18%)

At close: Sep 12, 2025, 4:00 PM EDT

10.12

+0.09 (0.90%)

After-hours: Sep 12, 2025, 7:40 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Needle-free Intranasal	30.00K	Log In
Needle-free Intranasal Growth	-97.72%	Log In

Revenue by Geography

Fiscal year is January - December.